Annie (Venkata) Narla, MD, MAS

Assistant Professor of Medicine, Division of Cardiology

Specialty Areas: Catheter ablation for ventricular tachycardia, atrial fibrillation, supraventricular tachycardia, PVCs; pacemaker and defibrillator implantation (including biventricular); sudden cardiac death; HIV-associated cardiovascular disease; resuscitation outcomes.

Chronology: MD: Johns Hopkins School of Medicine, 2008; Resident: Johns Hopkins Osler Internal Medicine, 2008-2011; Fellow, Cardiology: University of California, San Francisco 2011-2015; MAS, Masters of Advanced Study in Clinical Research: University of California, San Francisco 2013-2015; Fellow, Electrophysiology: University of California, San Francisco, 2015-2017.

Selected Honors: American College of Cardiology Merck Foundation Research Fellowship Award, 2014; Center for AIDS Research (CFAR) Mentored Scientist Award in HIV/AIDS, 2014; Institutional T32 National Research Service Award (NRSA), 2013. Finalist, Laennec Young Clinician Award, American Heart Association Scientific Sessions, 2013.

Selected Publications:

Narla VA, Tseng ZH. Sudden Cardiac Death in Multi-ethnic Populations. Current Cardiovascular Risk Reports. 2016 July; 10(27).

Narla V, Badhwar N. Provocative Drug Testing in the EP Lab. In Kartikeya Bhargava & Samuel Asirvatham (Eds.), Practical Cardiac Electrophysiology (pp. 717-721). JP Medical Ltd., 2017.

Waldo SW, Brenner DA, McCabe JM, Dela Cruz M, Long B, Narla VA, Park J, Kulkarni A, Sinclair E, Chan SY, Schick SF, Malik N, Ganz P, Hsue PY. A Novel Minimally-invasive Method to Sample Human Endothelial Cells for Molecular Profiling. PLoS One. 2015 Feb 13;10(2).

Whelton S, Narla VA, Blaha M, Nasir K, Blumenthal R, Jenny N, Al-Mallah M, Michos E. Association Between Resting Heart Rate and Inflammatory Biomarkers (High Sensitivity C-Reactive Protein, Interleukin-6, Fibrinogen) from the Multi-Ethnic Study of Atherosclerosis [MESA]. American Journal of Cardiology. 2014 Feb 15;113(4):644-9.

Narla V, Blaha M, Blumenthal R, Michos E. The Jupiter and Aurora Clinical Trials for Rosuvastatin in Special Primary Prevention Populations: Perspectives, Outcomes and Consequences. Vasc Health Risk Manag. 2009; 5:1033-1042

Narla V, Santos RD, Campbell CY, Carvalho JA, Nasir K, Budoff MJ, Blumenthal RS, Michos ED. Coronary Artery Calcification and Inflammation According to Various Metabolic Syndrome Definitions. J Cardiometab Syndr. 2009 Winter;4(1):33-9.

Michos E, Santos R, Narla V, Pandey S, Meneghelo R, Carvalho J, Budoff M, Blumenthal R, Nasir K. Favorable Cardiovascular Risk Factor Profile is Associated with Reduced Prevalence of
Coronary Artery Calcification and Inflammation in Asymptomatic Nondiabetic White Men
. Prev Cardiol. 2008 Fall;11(4):189-94.

  • Address

    Burnett-Womack Building

    Campus Box 7075

    Chapel Hill, NC 27599